A Double-Blind Randomized Comparison Trial of Postoperative Pain in Patients Undergoing Total Shoulder Arthroplasty Who Receive Interscalene Blocks With or Without Liposomal Bupivacaine (PoPTSAWoW Trial)
Latest Information Update: 12 Aug 2026
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms PoPTSAWoW Trial
Most Recent Events
- 29 Apr 2026 Status changed from recruiting to discontinued.
- 14 Aug 2025 Planned End Date changed from 1 Oct 2024 to 1 Mar 2026.
- 14 Aug 2025 Planned primary completion date changed from 1 Sep 2024 to 31 Dec 2025.